l9n/ Connecticut

2020 Regular Session

House Bill 5366

AN ACT CONCERNING THE COST OF PRESCRIPTION DRUGS.

Did not become law. It stopped in the House of Representatives on March 11, 2020. The 2020 session has ended.

What it does

The synopsis the General Assembly published with the bill.

To: (1) Cap aggregate monthly cost-sharing for prescription drugs covered under certain individual and group health insurance policies; (2) cap the cost of generic drugs in this state; (3) require the Commissioner of Consumer Protection to submit a request to the federal Secretary of Health and Human Services to implement a Canadian prescription drug reimportation program in this state and, if the secretary approves such request, implement such program in this state; (4) require pharmaceutical manufacturers to send notice to the Insurance Commissioner regarding "pay-for-delay" agreements, and require health carriers and pharmacy benefits managers to reduce the cost of brand name prescription drugs that are the subject of such agreements; (5) establish a Critical Drug Shortage Review Board; and (6) limit the circumstances in which a health carrier may remove a prescription drug from a drug formulary or list of covered drugs, or move a prescription drug to a different cost-sharing tier, during a plan year.

Sponsors

Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.

In the House of Representatives

In the Senate

    1 co-sponsor

    Saud Anwar

    Its course

    February 27 to March 11, 2020, on one scale. In the top row each mark is a day something happened; taller marks are busier days.

    Each committee stop sits inside its chamber.

    Every action4 actions on 4 days

    In the House of RepresentativesFeb 27 to Mar 11 · stopped13 days

    Insurance and Real Estate CommitteeFeb 27 to Mar 1012 days

    Text

    Each version as the General Assembly printed it.

    l9n doesn't hold this bill's text yet.

    What happened

    In l9n's words, one line for each step. Every action as the General Assembly published it is below.

    In the House of Representatives Feb 27 – Mar 10

    1. Feb 27Introduced and sent to Insurance and Real Estate Committee
    2. Feb 28Heard in Insurance and Real Estate Committee
    3. Mar 10Insurance and Real Estate Committee recommended a substitute for it
    All 4 actions, as published
    1. Feb 27REF. TO JOINT COMM. ONBoth houses
    2. Feb 28PUBLIC HEARINGBoth houses
    3. Mar 10Joint Favorable SubstituteBoth houses
    4. Mar 11FILED WITH LCOBoth houses